Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05241353 · ClinicalTrials.gov registry record · NA
Project THRIVE: Evaluating Different Approaches to Dietary Self-Monitoring for Weight Loss
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05241353: Completed NA study, sponsored by Drexel University.
NCT05241353 is a NA study that has completed, run by Drexel University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05241353, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This randomized pilot trial will compare two approaches to dietary self-monitoring for weight loss in the context of a low-intensity, remotely-delivered lifestyle modification program. Participants (N=40) will be randomized to perform detailed self-monitoring of all food and drink consumed each day or a reduced frequency, partial prescription involving recording only a subset of daily intake. The investigators will compare differences in weight loss as well as on relevant mechanistic, behavioral outcomes between groups at 12 weeks.
Primary Outcome
Weight will be assessed at baseline and weekly throughout the intervention. Participants will be instructed to self-weigh on one consistent morning per week before 11am, following specific instructions (i.e., wear light clothing, keep scale on a flat surface, weigh before eating or drinking) and then self-report weight using the Fitbit app where it can be later exported by research staff. Participants will be required to self-weigh using a reliable, digital wireless scale that can estimate weigh
Interventions
- BEHAVIORAL Standard Behavioral Treatment
- BEHAVIORAL Reduced Frequency Self-Monitoring
- BEHAVIORAL Full-Frequency Self-Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-04-25 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
What the finished NCT05241353 record still lists
NCT05241353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard Behavioral Treatment is the first listed.
NCT05241353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05241353 about?
NCT05241353 is a clinical study titled "Project THRIVE: Evaluating Different Approaches to Dietary Self-Monitoring for Weight Loss". This randomized pilot trial will compare two approaches to dietary self-monitoring for weight loss in the context of a low-intensity, remotely-delivered lifestyle modification program. Participants (N=40) will be randomized to perform detailed self-monitoring of all food and drink consumed each day ...
What is the current status of trial NCT05241353?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-04-25. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT05241353?
The interventions under investigation include: Standard Behavioral Treatment (BEHAVIORAL), Reduced Frequency Self-Monitoring (BEHAVIORAL), Full-Frequency Self-Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT05241353?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05241353's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI